(19)
(11) EP 4 771 631 A2

(12)

(88) Date of publication A3:
24.04.2025

(43) Date of publication:
08.07.2026 Bulletin 2026/28

(21) Application number: 24861247.5

(22) Date of filing: 30.08.2024
(51) International Patent Classification (IPC): 
G16B 40/20(2019.01)
G16H 50/70(2018.01)
G06N 20/00(2019.01)
G16C 20/70(2019.01)
G16B 20/20(2019.01)
C12Q 1/6809(2018.01)
G16B 20/40(2019.01)
G16H 50/30(2018.01)
(52) Cooperative Patent Classification (CPC):
G06N 20/00; G16B 20/20; G16H 50/30; G16H 50/70; G16H 10/40; G16H 15/00; G16H 50/50; G16H 40/67; G16H 50/20; G06N 7/01
(86) International application number:
PCT/US2024/044899
(87) International publication number:
WO 2025/050068 (06.03.2025 Gazette 2025/10)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 31.08.2023 US 202363579939 P
07.03.2024 US 202463562696 P

(71) Applicant: Laboratory Corporation of America Holdings
Burlington, North Carolina 27215 (US)

(72) Inventors:
  • MANDERS, Toby
    Burlington, North Carolina 27215 (US)
  • ARAYA, Carlos
    Burlington, North Carolina 27215 (US)
  • KOBAYASHI, Yuya
    Burlington, North Carolina 27215 (US)

(74) Representative: Carpmaels & Ransford LLP 
One Southampton Row
London WC1B 5HA
London WC1B 5HA (GB)

   


(54) CLINICAL VARIANT MODELING